OTC · HSTC
HST Global, Inc.
$0.70$0.00 (0.0%)
HST Global, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
Loading market information…
OTC · LIFS · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Life Stem Genetics Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.70$0.00 (0.0%)
HST Global, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
$0.00+$0.00 (+500.0%)
Scorpius Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.4% below the high.
$0.00$0.00 (0.0%)
Biostax Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
HEALTHeUNIVERSE, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Trevena, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.26% below the high.
$0.00$0.00 (0.0%)
Capital Group Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.12% below the high.
$0.00$0.00 (0.0%)
Infinity Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.15% below the high.
$0.00$0.00 (0.0%)
Aridis Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.6% below the high.
